FOXO TECHNOLOGIES INC (FOXO)

Company Profile

Foxo Technologies Inc is a US-based company operating in Software industry. The company is headquartered in Minneapolis, Minnesota and currently employs 24 full-time employees. The company went IPO on 2020-12-11. FOXO Technologies Inc. is a biotechnology company. The firm is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The firm operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.

Company Info

FOXO TECHNOLOGIES INC

729 Washington Ave. N, Suite 600

Minneapolis MINNESOTA

P: 16125629447

Employees: 24

Website: http://delwinds.com/